Infectious Diseases in Critical Care Medicine

(ff) #1

  1. Bouza E, Menasalvas A, Munoz P, et al. Infective endocarditis-A prospective study at the end of the
    twentieth century. Medicine 2001; 80:298–307.

  2. Gaynes R. Health care-associated bloodstream infections: a change in thinking. Ann Int Med 2003;
    137:850–851.

  3. Cabell CH, Jollis JG, Peterson GE, et al. Changing patient characteristics and the effect on mortality
    in endocarditis. Arch Int Med 2002; 162:90–95.

  4. Weinstein L, Schlesinger JJ. Anatomic, pathophysiologic and clinical correlations in endocarditis,
    N Engl J Med 1974; 291:832–837, 1122–1126.

  5. Brusch JL. Nosocomial and healthcare associated infective endocarditis (Iatrogenic Infective
    Endocarditis). In: Brusch JL, ed. Infective endocarditis, Management in the era of intravascular
    devices. New York: Informa Health Care, 2007:211–229.

  6. Garrison PK, Freedman LR. Experimental endocarditis. I staphylococcal endocarditis in rabbits
    resulting from placement of a polyethylene catheter in the right side of the heart. Yale J Biol Med
    1978; 22:394–410.

  7. Durack DT, Beeson PM, Petersdorf RG. Experimental bacterial endocarditis III. Production and
    progress of the disease in rabbits. Br J Exp Pathol 1972; 50:50–53.

  8. Rodbard S. Blood velocity and endocarditis. Circulation 1963; 27:18–28.

  9. Weinstein L., Brusch JL. Pathoanatomical, pathophysiological and clinical correlations, In: Weinstein
    L., Brusch JL, eds. Infective Endocarditis. New York: Oxford University Press, 1996:138–164.

  10. Everett ED, Hirschman JV. Transient bacteremia and endocarditis prophylaxis. a review. Medicine
    (Baltimore) 1977; 56:61–77.

  11. Loesche WJ. Indigenous human flora and bacteremia. In: Kaplan EL, Taranta AV, eds. Infective
    Endocarditis. Dallas: American Heart Association, 1977:40–45.

  12. Baskin RW, Rosenthal A, Bruitt BA. Acute bacterial endocarditis, a silent source of sepsis in the
    burn patient. Ann Surg 1976; 184:618–625.

  13. Weinstein L, Brusch JL. Pathoanatomical, pathophysiological and clinical correlations. In: Weinstein
    L, Brusch JL, eds. Infective Endocarditis. New York: Oxford University Press, 1995:138–164.

  14. Maki DG, Kluger DM, Cnrich CJ. The risk of bloodstream infections and adults with different
    intravascular devices: a systemic review of 200 published prospective studies. Mayo Clin Proc 2006;
    81:1159–1171.

  15. Maki DG. Infections caused by intravascular devices used for infusion therapy: pathogenesis,
    prevention and management. In: Bisno AL, Waldvogel FA, eds. Infections Associated with
    Indwelling Medical Devices. 2nd ed. Washington, DC: ASM Publishers, 1994:155–212.

  16. Kluger D, Maki D. The relative risk of intravascular device-related bloodstream infections with
    different types of intravascular devices in adults: a meta-analysis of 206 published studies
    (abstract). Infect Control Hosp Epidemiol 2000; 21: 95.

  17. Durack DT. Prevention of infective endocarditis. N Engl J Med 1995; 332: 38–44.

  18. Vaudaux P, Francois P, Lew DP, et al. Host factors predisposing to and influencing therapy of
    foreign body infections. In: Waldvogel FA, Bisno AL, eds. Infections Associated with Indwelling
    Medical Devices. 3rd. ed. Washington, DC: ASM Press, 2000:1–26.

  19. Sheretz RJ. Pathogenesis of vascular catheter infection. In: Waldvogel FA, Bisno AL, eds. Infections
    Associated with Indwelling Medical Devices. Washington, DC ASM Press, 2000:111–125.

  20. Sitges-Serra A, Linares J, Garau J. Catheter sepsis: the clue is the hub to. Surgery 1985; 97:355–357.

  21. Fowler VG, Justice A, Moorec, et al. Risk factors for hematogenous complications of intravascular
    catheter-associated Staphylococcus aureus bacteremia. Clin Infect Dis 2005; 40:695–703.

  22. Jarvis WR. Nosocomial outbreaks: The Centers For Disease Control’s hospital infections program
    experience. 1980–1991. Am J Med 1991; 91(suppl B): 101S–106 S.

  23. Jacobs MR, Good CE, Lazarus HM, et al. Relationship between bacterial load, species virulence and
    transfusion reaction with transfusion of bacterially contaminated platelets. Clin Infect Dis 2008;
    46:1214–1220.

  24. Macias AE, Ponce de Leon S, Huertas M, et al. Endemic infusate contamination and related
    bacteremia. Am J Infect Control 2008; 36:48–53.

  25. Snydman DR, Reidy MD, Perry LK, et al. Safety of changing intravenous (IV) administration sets
    containing burettes at longer than 48 hour intervals. Infect Control 1987; 8:113–116.

  26. Maki DG, Rhame FS, Mackel DC, et al. Nationwide epidemic of septicemia caused by contaminated
    intravenous products. Am J Med 1976; 60:471–485.

  27. Raad II, Baba M, Bodey GP. Diagnosis of catheter-related infections: the role of surveillance and
    targeted quantitative skin cultures. Clin Infect Dis 1995; 20:593–597.

  28. Parienti JJ. Femoral versus jugular venous catheterization and risk of nosocomial events in adults
    requiring acute renal replacement therapy: a randomized controlled trial. JAMA 2008; 299:
    2413–2422.


252 Brusch

Free download pdf